Detailansicht

Happl, B., Balber, T., Heffeter, P., Denk, C., Welch, J. M., Köster, U., Alliot, C., Bonraisin, A. C., Brandt, M., Haddad, F., Sterba, J. H., Kandioller, W., Mitterhauser, M., Hacker, M., Keppler, B. K., & Mindt, T. L. (2024). Synthesis and preclinical evaluation of BOLD-100 radiolabeled with ruthenium-97 and ruthenium-103. Dalton Transactions. https://doi.org/10.1039/d4dt00118d

Murgaš, M., Unterholzner, J., Stöhrmann, P., Philippe, C., Godbersen, G. M., Nics, L., Reed, M. B., Vraka, C., Vanicek, T., Wadsak, W., Kranz, G. S., Hahn, A., Mitterhauser, M., Hacker, M., Kasper, S., & Lanzenberger, R. (2023). Effects of bilateral sequential theta-burst stimulation on 5-HT_1A receptors in the dorsolateral prefrontal cortex in treatment-resistant depression: a proof-of-concept trial. Translational Psychiatry, 13(1), [33]. https://doi.org/10.1038/s41398-023-02319-3

Schmitl, S., Raitanen, J., Witoszynskyj, S., Patronas, E. M., Nics, L., Ozenil, M., Weissenböck, V., Mindt, T. L., Hacker, M., Wadsak, W., Brandt, M. R., & Mitterhauser, M. (2023). Quality Assurance Investigations and Impurity Characterization during Upscaling of [¹⁷⁷Lu]Lu-PSMA^I&T. Molecules, 28(23), [7696]. https://doi.org/10.3390/molecules28237696

Raitanen, J., Barta, B., Fuchs, H., Hacker, M., Balber, T., Georg, D., & Mitterhauser, M. (2023). Radiobiological Assessment of Targeted Radionuclide Therapy with [¹⁷⁷Lu]Lu-PSMA-I&T in 2D vs. 3D Cell Culture Models. International Journal of Molecular Sciences, 24(23), [17015]. https://doi.org/10.3390/ijms242317015

Scheibelberger, L., Stankovic, T., Pühringer, M., Kählig, H., Balber, T., Patronas, E. M., Rampler, E., Mitterhauser, M., Haschemi, A., & Pallitsch, K. (2023). Synthesis of 4-Deoxy-4-Fluoro-D-Sedoheptulose: A Promising New Sugar to Apply the Principle of Metabolic Trapping. Chemistry - A European Journal, 29(62), [e202302277]. https://doi.org/10.1002/chem.202302277

Happl, B., Brandt, M., Balber, T., Benčurová, K., Talip, Z., Voegele, A., Heffeter, P., Kandioller, W., Van der Meulen, N. P., Mitterhauser, M., Hacker, M., Keppler, B. K., & Mindt, T. L. (2023). Synthesis and Preclinical Evaluation of Radiolabeled [¹⁰³Ru]BOLD-100. Pharmaceutics, 15(11), [2626]. https://doi.org/10.3390/pharmaceutics15112626

Scheibelberger, L., Stankovic, T., Liepert, K., Kienzle, A., Patronas, E. M., Balber, T., Mitterhauser, M., Haschemi, A., & Pallitsch, K. (2023). Fluorinated Analogues to the Pentuloses of the Pentose Phosphate Pathway. European Journal of Organic Chemistry, 26(31), [e202300339]. https://doi.org/10.1002/ejoc.202300339

Raitanen, J., Barta, B., Hacker, M., Georg, D., Balber, T., & Mitterhauser, M. (2023). Comparison of Radiation Response between 2D and 3D Cell Culture Models of Different Human Cancer Cell Lines. Cells, 12(3), [360]. https://doi.org/10.3390/cells12030360

Atanasova, V. S., de Jesus Cardona, C., Hejret, V., Tiefenbacher, A., Mair, T., Tran, L., Pfneissl, J., Draganić, K., Binder, C., Kabiljo, J., Clement, J., Woeran, K., Neudert, B., Wohlhaupter, S., Haase, A., Domazet, S., Hengstschläger, M., Mitterhauser, M., Müllauer, L., ... Egger, G. (2023). Mimicking Tumor Cell Heterogeneity of Colorectal Cancer in a Patient-derived Organoid-Fibroblast Model. CMGH, 15(6), 1391-1419. https://doi.org/10.1016/j.jcmgh.2023.02.014

al Jalali, V., Wasinger, G., Rasul, S., Grubmüller, B., Wulkersdorfer, B., Balber, T., Mitterhauser, M., Simon, J., Hacker, M., Shariat, S., Egger, G., & Zeitlinger, M. (2023). Consecutive Prostate-Specific Membrane Antigen (PSMA) and Antigen Receptor (AR) PET Imaging Shows Positive Correlation with AR and PSMA Protein Expression in Primary Hormone-Naïve Prostate Cancer. Journal of Nuclear Medicine, 64(6), 863-868. https://doi.org/10.2967/jnumed.122.264981

Kiss, A., Wu, P., Schlederer, M., Pilz, P. M., Szabo, P. L., Li, J., Weber, L., Vraka, C., Pichler, V., Mitterhauser, M., Zhang, X., Zins, K., Abraham, D., Li, S., Podesser, B. K., Hacker, M., & Li, X. (2022). Sympathetic nerve innervation and metabolism in ischemic myocardium in response to remote ischemic perconditioning. Basic research in cardiology, 117(1), [42]. https://doi.org/10.1007/s00395-022-00946-3

Bamminger, K., Raitanen, J., Karanikas, G., Rasul, S., Nics, L., Mitterhauser, M., Wadsak, W., Hacker, M., Pichler, V., & Vraka, C. (2022). Rapid, high-yield enzymatic synthesis of n.c.a. 6-[¹⁸F]fluorodopamine (6-[¹⁸F]FDA) for in vivo application. Nuclear Medicine and Biology, 114-115, 189-197. https://doi.org/10.1016/j.nucmedbio.2022.07.001

Klebermass, E. M., Dengler, A., Weissenböck, V., Ricken, G., Wadsak, W., Viernstein, H., Hacker, M., Mitterhauser, M., & Philippe, C. (2022). Autoradiography on deparaffinized tissue sections – A feasibility study with ⁶⁸Ga-labeled PET-tracers. Applied Radiation and Isotopes, 189, [110425]. https://doi.org/10.1016/j.apradiso.2022.110425

Bencurova, K., Friske, J., Anderla, M., Mayrhofer, M., Wanek, T., Nics, L., Egger, G., Helbich, T. H., Hacker, M., Haug, A., Mitterhauser, M., & Balber, T. (2022). CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [⁶⁸Ga]Ga-Pentixafor in CRC Imaging. Cancers, 14(22), [5549]. https://doi.org/10.3390/cancers14225549

Balber, T., Raitanen, J., Benčurová, K., Franssen, T., Schwarzl, P., Kalla, J., Culig, Z., Hacker, M., Egger, G., & Mitterhauser, M. (2022). In vitro investigation of a potential complementary expression of the imaging biomarkers AR and PSMA during prostate cancer progression. European Journal of Nuclear Medicine and Molecular Imaging, 49(Suppl.1), S329-S330.

Rischka, L., Vraka, C., Pichler, V., Rasul, S., Nics, L., Gryglewski, G., Handschuh, P., Murgas, M., Godbersen, G. M., Silberbauer, L. R., Unterholzner, J., Wotawa, C., Haider, A., Ahmed, H., Schibli, R., Mindt, T., Mitterhauser, M., Wadsak, W., Hahn, A., ... Ametamey, S. M. (2022). First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-D-aspartate Receptor with (R)-C-11-Me-NB1. Journal of Nuclear Medicine, 63(6), 936-941. https://doi.org/10.2967/jnumed.121.262427

Rasul, S., Beitzke, D., Wollenweber, T., Rausch, I., Lassen, M. L., Stelzmüller, M. E., Mitterhauser, M., Pichler, V., Beyer, T., Loewe, C., & Hacker, M. (2022). Assessment of left and right ventricular functional parameters using dynamic dual-tracer [¹³N]NH3 and [¹⁸F]FDG PET/MRI. Journal of Nuclear Cardiology, 29(3), 1003-1017. https://doi.org/10.1007/s12350-020-02391-y

Vraka, C., Murgaš, M., Rischka, L., Geist, B. K., Lanzenberger, R., Gryglewski, G., Zenz, T., Wadsak, W., Mitterhauser, M., Hacker, M., Philippe, C., & Pichler, V. (2022). Simultaneous radiomethylation of [¹¹C]harmine and [¹¹C]DASB and kinetic modeling approach for serotonergic brain imaging in the same individual. Scientific Reports, 12(1), [3283]. https://doi.org/10.1038/s41598-022-06906-0

Balber, T., Tran, L., Bencurova, K., Raitanen, J., Egger, G., & Mitterhauser, M. (2022). Experimental Nuclear Medicine Meets Tumor Biology. Pharmaceuticals, 15(2), [227]. https://doi.org/10.3390/ph15020227

Rischka, L., Murgaš, M., Pichler, V., Vraka, C., Rausch, I., Winkler, D., Nics, L., Rasul, S., Silberbauer, L. R., Reed, M. B., Godbersen, G. M., Unterholzner, J., Handschuh, P., Gryglewski, G., Mindt, T., Mitterhauser, M., Hahn, A., Ametamey, S. M., Wadsak, W., ... Hacker, M. (2022). Biodistribution and dosimetry of the GluN2B-specific NMDA receptor PET radioligand (R)-[¹¹C]Me-NB1. EJNMMI Research, 12(1), [53]. https://doi.org/10.1186/s13550-022-00925-8